Document ID: chunk:federal_register_of_legislation:F2024C01086:clause:1_18360
Version: federal_register_of_legislation:F2024C01086
Segment Type: clause
Provision Reference: sch 1 cl 18360
Character Range: 1034252–1035402

18360                      Botulinum Toxin Type A Purified Neurotoxin Complex (Botox) or Clostridium Botulinum Type A Toxin Haemagglutinin Complex (Dysport), injection of, for the treatment of moderate to severe focal spasticity if:                                                                                                                                                                                  129.90
                           (a) the patient is at least 18 years of age; and
                           (b) the spasticity is associated with a previously diagnosed neurological disorder; and
                           (c) the treatment is provided as:
                           (i) second line therapy when standard treatment for the condition has failed; or
                           (ii) an adjunct to physical therapy; and
                           (d) the treatment is for all or any of the muscles subserving one functional activity and supplied by one motor nerve, with a maximum of 4 sets of injections for the patient on any one day (with a maximum of 2 sets of injections for each limb), including all injections per set